Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist
February 12 2025 - 9:40AM
AllPennyStocks.com
Today was a big day for one small cap biotech
company. The company announced that they had acquired worldwide
exclusive license rights to a late-stage Toll-like Receptor 5
(TLR5)...
To read the full story on AllPennyStocks.com, click
here.
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Jan 2025 to Feb 2025
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Feb 2024 to Feb 2025